Search Results

There are 24447 results for: content related to: Current Literature Review

  1. You have free access to this content
    The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study

    BJU International

    Volume 107, Issue 9, May 2011, Pages: 1426–1431, Francesco Montorsi, Claus Roehrborn, Javier Garcia-Penit, Michael Borre, Ton A. Roeleveld, Jean-Charles Alimi, Paul Gagnier and Timothy H. Wilson

    Version of Record online : 23 FEB 2011, DOI: 10.1111/j.1464-410X.2011.10129.x

  2. Improvement of Overactive Bladder Symptoms and Bladder Ischemia with Dutasteride in Patients with Benign Prostatic Enlargement

    LUTS: Lower Urinary Tract Symptoms

    Volume 7, Issue 1, January 2015, Pages: 37–41, Naoki WADA, Seiji MATSUMOTO, Masafumi KITA, Kazumi HASHIZUME and Hidehiro KAKIZAKI

    Version of Record online : 24 FEB 2014, DOI: 10.1111/luts.12047

  3. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1542–1549, Bushra Ateeq, Adaikkalam Vellaichamy, Scott A. Tomlins, Rui Wang, Qi Cao, Robert J. Lonigro, Kenneth J. Pienta and Sooryanarayana Varambally

    Version of Record online : 13 MAR 2012, DOI: 10.1002/pros.22509

  4. You have free access to this content
    Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial

    BJU International

    Volume 107, Issue 6, March 2011, Pages: 946–954, Claus G. Roehrborn, Jack Barkin, Paul Siami, Andrea Tubaro, Timothy H. Wilson, Betsy B. Morrill and R. Paul Gagnier

    Version of Record online : 18 FEB 2011, DOI: 10.1111/j.1464-410X.2011.10124.x

  5. You have free access to this content
    Early effect of dutasteride added to alpha-1 blocker therapy for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

    International Journal of Urology

    Volume 21, Issue 8, August 2014, Pages: 815–819, Kazuhiro Araki, Yukio Naya, Masahiko Inahara, Fumio Suzuki, Syo Ota, Hirokatsu Tsuji, Kazuo Mikami, Mitsuru Yanagisawa, Yusuke Awa and Hiroyoshi Suzuki

    Version of Record online : 15 APR 2014, DOI: 10.1111/iju.12459

  6. You have free access to this content
    Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

    BJU International

    Volume 108, Issue 3, August 2011, Pages: 388–394, J. Curtis Nickel, Peter Gilling, Teuvo L. Tammela, Betsy Morrill, Timothy H. Wilson and Roger S. Rittmaster

    Version of Record online : 1 JUN 2011, DOI: 10.1111/j.1464-410X.2011.10195.x

  7. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride

    International Journal of Clinical Practice

    Volume 66, Issue 11, November 2012, Pages: 1052–1055, S. A. Kaplan, D. E. Chung, R. K. Lee, S. Scofield and A. E. Te

    Version of Record online : 16 OCT 2012, DOI: 10.1111/j.1742-1241.2012.03010.x

    Corrected by:

    Erratum: Erratum

    Vol. 67, Issue 3, 291, Version of Record online: 15 FEB 2013

  8. You have free access to this content
    Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study

    BJU International

    Volume 113, Issue 4, April 2014, Pages: 623–635, Claus G. Roehrborn, Jack Barkin, Andrea Tubaro, Mark Emberton, Timothy H. Wilson, Betsy J. Brotherton and Ramiro Castro

    Version of Record online : 9 JAN 2014, DOI: 10.1111/bju.12500

  9. You have free access to this content
    Gene Expression in Prostate Cancer Cells Treated With the Dual 5 Alpha-Reductase Inhibitor Dutasteride

    Journal of Andrology

    Volume 25, Issue 6, November-December 2004, Pages: 944–953, Lucy J. Schmidt, Horacio Murillo and Donald J. Tindall

    Version of Record online : 2 JAN 2013, DOI: 10.1002/j.1939-4640.2004.tb03166.x

  10. Dutasteride, the dual 5α–reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line

    The Prostate

    Volume 58, Issue 2, 1 February 2004, Pages: 130–144, C.B. Lazier, L.N. Thomas, R.C. Douglas, J.P. Vessey and R.S. Rittmaster

    Version of Record online : 17 NOV 2003, DOI: 10.1002/pros.10340

  11. You have free access to this content
    Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride

    International Journal of Dermatology

    Volume 53, Issue 11, November 2014, Pages: 1351–1357, Jae Yoon Jung, Je Ho Yeon, Jee Woong Choi, Soon Hyo Kwon, Beom Joon Kim, Sang Woong Youn, Kyoung Chan Park and Chang Hun Huh

    Version of Record online : 5 JUN 2014, DOI: 10.1111/ijd.12060

  12. You have free access to this content
    Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study

    BJU International

    Volume 109, Issue 8, April 2012, Pages: 1162–1169, Michael Marberger, Stephen J. Freedland, Gerald L. Andriole, Mark Emberton, Curtis Pettaway, Francesco Montorsi, Claudio Teloken, Roger S. Rittmaster, Matthew C. Somerville and Ramiro Castro

    Version of Record online : 23 JUN 2011, DOI: 10.1111/j.1464-410X.2011.10373.x

  13. You have free access to this content
    A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer

    BJU International

    Volume 108, Issue 8b, October 2011, Pages: E164–E170, Hans T. Chung, Susan M. Noworolski, John Kurhanewicz, Vivian Weinberg and Mack Roach III

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1464-410X.2010.10061.x

  14. Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts

    The Prostate

    Volume 69, Issue 16, 1 December 2009, Pages: 1730–1743, Lucy J. Schmidt, Kevin M. Regan, S. Keith Anderson, Zhifu Sun, Karla V. Ballman and Donald J. Tindall

    Version of Record online : 12 AUG 2009, DOI: 10.1002/pros.21022

  15. You have free access to this content
    Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia

    International Journal of Urology

    Volume 16, Issue 9, September 2009, Pages: 745–750, Taiji Tsukamoto, Yukihiro Endo and Michiro Narita

    Version of Record online : 5 AUG 2009, DOI: 10.1111/j.1442-2042.2009.02357.x

  16. Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 117–123, Gian Maria Busetto, Riccardo Giovannone, Gabriele Antonini, Antonella Rossi, Francesco Del Giudice, Stefano Tricarico, Giulia Ragonesi, Vincenzo Gentile and Ettore De Berardinis

    Version of Record online : 21 JAN 2015, DOI: 10.1111/bju.12917

  17. You have free access to this content
    5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review

    BJU International

    Volume 106, Issue 10, November 2010, Pages: 1444–1451, Timothy J. Wilt, Roderick MacDonald, Karen Hagerty, Paul Schellhammer, James Tacklind, Mark R. Somerfield and Barnett S. Kramer

    Version of Record online : 27 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09714.x

    Corrected by:

    Corrigendum

    Vol. 107, Issue 2, 344, Version of Record online: 5 JAN 2011

  18. Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride

    The Prostate

    Volume 67, Issue 10, 1 July 2007, Pages: 1111–1120, Lucy J. Schmidt, Karla V. Ballman and Donald J. Tindall

    Version of Record online : 3 MAY 2007, DOI: 10.1002/pros.20602

  19. Efficacy of Additional Dutasteride on Lower Urinary Tract Symptoms in Patients with Alpha-1 Blocker-Resistant Benign Prostatic Hyperplasia

    LUTS: Lower Urinary Tract Symptoms

    Volume 5, Issue 3, September 2013, Pages: 159–163, Atsushi SENGIKU, Yu MIYAZAKI, Harutake SAWAZAKI, Takeshi TAKAHASHI and Keiji OGURA

    Version of Record online : 28 JAN 2013, DOI: 10.1111/luts.12010

  20. The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study

    The Prostate

    Volume 66, Issue 15, November 2006, Pages: 1674–1685, M. Gleave, J. Qian, C. Andreou, P. Pommerville, J. Chin, R. Casey, G. Steinhoff, N. Fleshner, D. Bostwick, L. Thomas and R. Rittmaster

    Version of Record online : 22 AUG 2006, DOI: 10.1002/pros.20499